Viewing data from:

VENETOCLAX

ANDA

VENETOCLAX | A214733 | DR REDDYS LABORATORIES LTD

3 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: VENCLEXTA(TE code: AB)

Hatch-Waxman Litigation

1 case on OB patents from PACER

Case	Court	Filed	Status	Judge
ABBVIE INC. et al v. DR. REDDY'S LABORATORIES, INC. 3:2020cv09292 4 patentsANDA 214733venetoclax	D.N.J.	2020-07-22	Terminated 2020-08-28	—

Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).

API Supply Chain10 active DMFs

9 active API suppliers hold Drug Master Files for this ingredient.

DR REDDYS LABORATORIES LTDVENETOCLAX

DMF 336692019

MSN LABORATORIES PRIVATE LTDVENETOCLAX

DMF 340222019

ALEMBIC PHARMACEUTICALS LTDVENETOCLAX

DMF 341402019

CHANGZHOU PHARMACEUTICAL FACTORYVENETOCLAX

DMF 392892023

HETERO LABS LTDVENETOCLAX

DMF 402692024

NATCO PHARMA LTDVENETOCLAX

DMF 407202024

PORTON PHARMA SOLUTIONS LTDVENETOCLAX

DMF 417102025

XUZHOU WANBANG JINQIAO PHARMA CO LTDVENETOCLAX

DMF 430062025

CHENGDA PHARMACEUTICALS CO LTDVENETOCLAX INTERMEDIATE (CAS NO.:1628047-87-9)

DMF 431432025

CHENGDA PHARMACEUTICALS CO LTDVENETOCLAX INTERMEDIATE (CAS NO.:1228779-96-1)

DMF 431442025

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 10MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: May 15, 2026

No patent or exclusivity listings for this strength.

#002 — 50MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: May 15, 2026

#003 — 100MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: May 15, 2026